Merck (MRK) Interest Expenses (2011 - 2013)

Merck (MRK) has 3 years of Interest Expenses data on file, last reported at $184.0 million in Q1 2013.

• Interest Expenses for Q1 2013 came in at $184.0 million, up 5.14% year-over-year; the trailing twelve-month figure through Dec 2013 was $184.0 million (down 74.27% YoY), and the FY2012 annual result was $714.0 million, up 2.73% from the prior year.
• Interest Expenses declined to $184.0 million in Q1 2013 per MRK's latest filing, from $190.0 million in the prior quarter.
• Over five years, Interest Expenses peaked at $190.0 million in Q4 2012 and troughed at $170.0 million in Q2 2011.
• A 3-year average of $178.2 million and a median of $176.0 million in 2011 frame the typical range for Interest Expenses.
• On a YoY basis, Interest Expenses climbed as much as 9.83% in 2012 and fell as far as 5.91% in 2012.
• A 3-year view of Interest Expenses shows it stood at $173.0 million in 2011, then climbed by 9.83% to $190.0 million in 2012, then dropped by 3.16% to $184.0 million in 2013.
• Business Quant data shows MRK's Interest Expenses at $184.0 million in Q1 2013, $190.0 million in Q4 2012, and $178.0 million in Q3 2012.